ACTRN12618001441202: A Phase I Study to Determine the Safety of Multiple Oral Doses of Niclosamide in Healthy Volunteers |
|
|
| Not yet recruiting | 1 | 12 | | | Ala Wai Pharma Pty Ltd, Ala Wai Pharma Pty Ltd | Therapeutic for Zika virus treatment | | | | |
NCT02532114: Niclosamide and Enzalutamide in Treating Patients With Castration-Resistant, Metastatic Prostate Cancer |
|
|
| Completed | 1 | 5 | US | Enzalutamide, ASP9785, MDV3100, Xtandi, Laboratory Biomarker Analysis, Niclosamide, Pharmacological Study | University of Washington, National Cancer Institute (NCI) | Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Adenocarcinoma | 11/17 | 11/17 | | |
NCT03123978: Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer |
|
|
| Completed | 1 | 6 | US | Enzalutamide, ASP9785, MDV3100, Xtandi, Niclosamide | Mamta Parikh, National Cancer Institute (NCI), Pandomedx | Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer | 01/22 | 04/22 | | |
NCT05168644: Single Ascending Dose and Multiple Ascending Dose Study of Niclosamide Inhalation Powder in Healthy Adult Subjects |
|
|
| Completed | 1 | 40 | Canada | Niclosamide Inhalation Powder, Placebo | TFF Pharmaceuticals, Inc. | Healthy | 01/22 | 01/22 | | |
